Oncimmune: Oncimmune setting its sights on the interplay between autoantibodies and age-related conditions
Oncimmune Holdings plc, a prominent autoantibody profiling company catering to the pharmaceutical and biotechnology sectors, is expanding its horizons by delving into the realm of biomarkers for age-related diseases.
Read full article »
CEO
- -Oncimmune is an England-based biotechnology company that develops an analytical platform for the discovery of immunodiagnostic antibody biomarker signatures.
Read more